Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bandel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Impotence Research|August 9, 2001
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trialH Porst, R Rosen, H Padma-Nathan, et al.
Der Urologe. Ausg. A|August 13, 1999
[Occupational risk factors for bladder carcinoma. A case control study]K Golka, T Bandel, T Reckwitz, et al.
International Journal of Occupational and Environmental Health|February 23, 1999
Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: a case-control studyK Golka, T Bandel, S Schlaefke, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Impotence Research|August 9, 2001
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trialH Porst, R Rosen, H Padma-Nathan, et al.
Der Urologe. Ausg. A|August 13, 1999
[Occupational risk factors for bladder carcinoma. A case control study]K Golka, T Bandel, T Reckwitz, et al.
International Journal of Occupational and Environmental Health|February 23, 1999
Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: a case-control studyK Golka, T Bandel, S Schlaefke, et al.
Pageof 1